BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2768839)

  • 1. Improved detection of aneuploidy in malignant melanoma using multiparameter flow cytometry for S100 protein and DNA content.
    Kamino H; Ratech H
    J Invest Dermatol; 1989 Sep; 93(3):392-6. PubMed ID: 2768839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
    Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
    Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
    von Roenn JH; Kheir SM; Wolter JM; Coon JS
    Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
    Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
    Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.
    Kheir SM; Bines SD; Vonroenn JH; Soong SJ; Urist MM; Coon JS
    Ann Surg; 1988 Apr; 207(4):455-61. PubMed ID: 3355269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
    Ohnishi K; Ishikawa H
    Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma?
    Gattuso P; Reddy V; Solans E; Kathuria S; Aranha GV; Jacobs HK; Walloch J
    Surgery; 1990 Oct; 108(4):702-8; discussion 708-9. PubMed ID: 2218882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA image cytometry on sections as compared with image cytometry on smears and flow cytometry in melanoma.
    Klapperstück T; Wohlrab W
    Cytometry; 1996 Sep; 25(1):82-9. PubMed ID: 8875057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary malignant melanoma of the skin. Relationships of nuclear DNA content, nuclear morphometric variables, Clark level and tumor thickness.
    Talve LA; Collan YU; Ekfors TO
    Anal Quant Cytol Histol; 1997 Feb; 19(1):62-74. PubMed ID: 9051188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow and video-imaging cytometry--usefulness of DNA ploidy measurements in diagnosis of malignant melanoma.
    Skowronek J; Karaś Z; Krenz RM; Warchoł JB
    Adv Exp Med Biol; 2001; 495():435-8. PubMed ID: 11774606
    [No Abstract]   [Full Text] [Related]  

  • 12. DNA ploidy of malignant melanoma determined by image cytometry of fresh frozen and paraffin-embedded tissue.
    Herzberg AJ; Kerns BJ; Borowitz MJ; Seigler HF; Kinney RB
    J Cutan Pathol; 1991 Dec; 18(6):440-8. PubMed ID: 1774354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
    Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
    Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application.
    Nakajima T; Watanabe S; Sato Y; Kameya T; Shimosato Y; Ishihara K
    Cancer; 1982 Sep; 50(5):912-8. PubMed ID: 6807528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus.
    Rode J; Williams RA; Jarvis LR; Dhillon AP; Jamal O
    J Pathol; 1990 May; 161(1):41-5. PubMed ID: 2370597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small malignant melanomas: clinicopathologic correlation and DNA ploidy analysis.
    Kamino H; Kiryu H; Ratech H
    J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):1032-8. PubMed ID: 2370327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demonstration of S 100 protein in malignant melanoma of the skin. Pattern of distribution and significance for determination of tumor thickness].
    Flügge G; Rassner G
    Hautarzt; 1989 May; 40(5):290-5. PubMed ID: 2661501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P90 exceeding rate as a prognostic factor in primary malignant melanoma of the skin. A DNA image cytometric study.
    Talve LA; Collan YU; Ekfors TO
    Anal Quant Cytol Histol; 1997 Oct; 19(5):393-403. PubMed ID: 9349899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100 protein: a marker for human malignant melanomas?
    Gaynor R; Herschman HR; Irie R; Jones P; Morton D; Cochran A
    Lancet; 1981 Apr; 1(8225):869-71. PubMed ID: 6112296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell sarcomas and metastatic soft tissue melanomas. A flow cytometric comparison and prognostic implications.
    el-Naggar AK; Ordóñez NG; Sara A; McLemore D; Batsakis JG
    Cancer; 1991 Apr; 67(8):2173-9. PubMed ID: 2004337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.